Activated CD8+ CTLs recognize and eliminate virus-infected tumor cells [76], while CD4+ helper T cells enhance CTL function and stimulate B-cell antibody production by secreting cytokines (e.g., IFN-γ, IL-2); these cytokines ultimately mediate tumor cell killing through mechanisms including complement activation (Fig. 1d). This evidence concerns the gene CD8A and neoplasm.